LI-RADS major features: CT, MRI with extracellular agents, and MRI with hepatobiliary agents

被引:49
|
作者
Santillan, Cynthia [1 ]
Fowler, Kathryn [2 ]
Kono, Yuko [3 ]
Chernyak, Victoria [4 ]
机构
[1] Univ Calif San Diego, Dept Radiol, Liver Imaging Grp, San Diego, CA 92103 USA
[2] Washington Univ, Mallinckrodt Inst Radiol, St Louis, MO USA
[3] Univ Calif San Diego, Dept Radiol, Dept Med, San Diego, CA 92103 USA
[4] Montefiore Med Ctr, Dept Radiol, 111 E 210th St, Bronx, NY 10467 USA
关键词
Hepatocellular carcinoma; Liver; MRI; CT; LI-RADS; CONTRAST-ENHANCED CT; HEPATOCELLULAR-CARCINOMA; INTRAHEPATIC CHOLANGIOCARCINOMA; COMPUTED-TOMOGRAPHY; HEPATIC NODULES; GROWTH-RATE; DIAGNOSIS; CIRRHOSIS; PATTERNS; LIVER;
D O I
10.1007/s00261-017-1291-4
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The Liver Imaging Reporting and Data System (LI-RADS) was designed to standardize the interpretation and reporting of observations seen on studies performed in patients at risk for development of hepatocellular carcinoma (HCC). The LI-RADS algorithm guides radiologists through the process of categorizing observations on a spectrum from definitely benign to definitely HCC. Major features are the imaging features used to categorize observations as LI-RADS 3 (intermediate probability of malignancy), LIRADS 4 (probably HCC), and LI-RADS 5 (definite HCC). Major features include arterial phase hyperenhancement, washout appearance, enhancing capsule appearance, size, and threshold growth. Observations that have few major criteria are assigned lower categories than those that have several, with the goal of preserving high specificity for the LR-5 category of Definite HCC. The goal of this paper is to discuss LI-RADS major features, including definitions, rationale for selection as major features, and imaging examples.
引用
收藏
页码:75 / 81
页数:7
相关论文
共 50 条
  • [1] LI-RADS major features: CT, MRI with extracellular agents, and MRI with hepatobiliary agents
    Cynthia Santillan
    Kathryn Fowler
    Yuko Kono
    Victoria Chernyak
    Abdominal Radiology, 2018, 43 : 75 - 81
  • [2] LI-RADS Tumor in Vein at CT and Hepatobiliary MRI
    Bae, Jae Seok
    Lee, Jeong Min
    Jeon, Sun Kyung
    Yoo, Jeongin
    Park, Sae-Jin
    Yoon, Jeong Hee
    Joo, Ijin
    Lee, Kyoung-Bun
    Kim, Haeryoung
    RADIOLOGY, 2022, 302 (01) : 107 - 115
  • [3] LI-RADS® ancillary features on CT and MRI
    Chernyak, Victoria
    Tang, An
    Flusberg, Milana
    Papadatos, Demetri
    Bijan, Bijan
    Kono, Yuko
    Santillan, Cynthia
    ABDOMINAL RADIOLOGY, 2018, 43 (01) : 82 - 100
  • [4] Hepatobiliary agents and their role in LI-RADS
    Hope, Thomas A.
    Fowler, Kathryn J.
    Sirlin, Claude B.
    Costa, Eduardo A. C.
    Yee, Judy
    Yeh, Benjamin M.
    Heiken, Jay P.
    ABDOMINAL IMAGING, 2015, 40 (03): : 613 - 625
  • [5] LI-RADS® ancillary features on CT and MRI
    Victoria Chernyak
    An Tang
    Milana Flusberg
    Demetri Papadatos
    Bijan Bijan
    Yuko Kono
    Cynthia Santillan
    Abdominal Radiology, 2018, 43 : 82 - 100
  • [6] Hepatobiliary agents and their role in LI-RADS
    Thomas A. Hope
    Kathryn J. Fowler
    Claude B. Sirlin
    Eduardo A. C. Costa
    Judy Yee
    Benjamin M. Yeh
    Jay P. Heiken
    Abdominal Imaging, 2015, 40 : 613 - 625
  • [7] LI-RADS® algorithm: CT and MRI
    Chernyak, Victoria
    Santillan, Cynthia S.
    Papadatos, Demetri
    Sirlin, Claude B.
    ABDOMINAL RADIOLOGY, 2018, 43 (01) : 111 - 126
  • [8] LI-RADS® algorithm: CT and MRI
    Victoria Chernyak
    Cynthia S. Santillan
    Demetri Papadatos
    Claude B. Sirlin
    Abdominal Radiology, 2018, 43 : 111 - 126
  • [9] Is MRI Better than CT for the LI-RADS?
    Ronot, Maxime
    RADIOLOGY, 2023, 307 (01)
  • [10] Contrast-enhanced ultrasound LI-RADS 2017: comparison with CT/MRI LI-RADS
    Ding, Jianmin
    Long, Lei
    Zhang, Xiang
    Chen, Chen
    Zhou, Hongyu
    Zhou, Yan
    Wang, Yandong
    Jing, Xiang
    Ye, Zhaoxiang
    Wang, Fengmei
    EUROPEAN RADIOLOGY, 2021, 31 (02) : 847 - 854